STELIS BIOPHARMA
Stelis Biopharma is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from Cell line and Process Development through to scale up, cGMP manufacturing, and fills/finish of proteins and peptides. Offer services at every stage of the development life cycle from Pre-Clinical and Clinical Development to Commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO ... services, our deep commitment to Quality, Service, and Compliance. Stelis Biopharma Pvt. Ltd. (Stelis) was started in 2013 by Strides Pharma Science Limited (Strides) to drive a global affordable biopharma business. Via on-going investment, Strides remains a majority owner of Stelis alongside GMS Holdings and Tenshi Life Sciences. It continues to operate as an independent and autonomous subsidiary company.
STELIS BIOPHARMA
Industry:
Biopharma Biotechnology Life Science Therapeutics
Founded:
2013-01-01
Address:
Bangalore, Karnataka, India
Country:
India
Website Url:
http://www.stelisbiosource.com
Total Employee:
251+
Status:
Active
Contact:
+91 80 6784 0444
Email Addresses:
[email protected]
Total Funding:
230 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail ReCAPTCHA GoDaddy DNS AWS Global Accelerator ReCAPTCHA V3 Mailgun MailChannels
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Current Employees Featured
Founder
Investors List
GMS Holdings
GMS Holdings investment in Series B - Stelis Biopharma
RouteOne
RouteOne investment in Series C - Stelis Biopharma
Strides Pharma Science
Strides Pharma Science investment in Series B - Stelis Biopharma
Mankekar Family Office
Mankekar Family Office investment in Series C - Stelis Biopharma
Think Investments
Think Investments investment in Series C - Stelis Biopharma
TPG Growth
TPG Growth investment in Series C - Stelis Biopharma
GMS Holdings
GMS Holdings investment in Series C - Stelis Biopharma
Tenshi Life Sciences
Tenshi Life Sciences investment in Series B - Stelis Biopharma
Strides Pharma Science
Strides Pharma Science investment in Series B - Stelis Biopharma
GMS Holdings
GMS Holdings investment in Series B - Stelis Biopharma
Official Site Inspections
http://www.stelisbiosource.com
- Host name: 172.67.145.157
- IP address: 172.67.145.157
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
